Richard L. Friedman is the Director of the Division of Manufacturing & Product Quality in the Center for Drug Evaluation and Research (CDER). In this position, he directs the evaluation of drug inspection regulatory recommendations as well as interpretation and development of CGMP policy. He has been employed by FDA since 1990, including prior positions as New Jersey district drug specialist, CDER senior compliance officer, and team leader of guidance and policy. Friedman is an adjunct faculty member of Temple University School of Pharmacy in their QA/RA graduate program. He has authored several publications on topics including sterile drugs and quality management systems, and was awarded The George M. Sykes Award by the Parenteral Society for outstanding journal paper for the year 2005. Prior to joining FDA, Friedman worked in the toxicology research division of an innovator pharmaceutical company. Friedman received his BS in biology with honors from Montclair State University in 1989 and his MS in microbiology from Georgetown University School of Medicine in May 2001.